Literature DB >> 7565538

Assessing the effectiveness of disease and injury prevention programs: costs and consequences.

.   

Abstract

Because resources are finite, public health decision makers need to consider the costs and effectiveness of alternative prevention strategies. A simplified approach to performing marginal cost-effectiveness analyses requires a) a description of the program, b) a description of the health outcomes averted and the timing of those events, c) the rates of the health outcome, d) the preventable fraction of the health outcomes averted, e) the costs per unit of the intervention, and f) the direct medical costs of the health outcome prevented and the side effects incurred. With this information, the marginal cost-effectiveness of an intervention can be determined and applied for decision making.

Entities:  

Mesh:

Year:  1995        PMID: 7565538

Source DB:  PubMed          Journal:  MMWR Recomm Rep        ISSN: 1057-5987


  4 in total

1.  Prevention for HIV-seropositive persons: successive approximation toward a new identity.

Authors:  Marguerita Lightfoot; Mary Jane Rotheram-Borus; Norweeta G Milburn; Dallas Swendeman
Journal:  Behav Modif       Date:  2005-03

2.  20 Years of Public Health Economics and Decision Sciences at the US Centers for Disease Control and Prevention: The CDC Steven M. Teutsch Prevention Effectiveness Fellowship, 1995-2015.

Authors:  Adam G Skelton; Martin I Meltzer
Journal:  J Public Health Manag Pract       Date:  2017 Jul/Aug

3.  When there is too much to do: how practicing physicians prioritize among recommended interventions.

Authors:  Timothy P Hofer; Judith K Zemencuk; Rodney A Hayward
Journal:  J Gen Intern Med       Date:  2004-06       Impact factor: 5.128

4.  Net financial benefits of averting HIV infections among people who inject drugs in Urumqi, Xinjiang, Peoples Republic of China (2005-2010).

Authors:  Mingjian J Ni; Li Ping Fu; Xue Ling Chen; Xiao Yuan Hu; Kim Wheeler
Journal:  BMC Public Health       Date:  2012-07-29       Impact factor: 3.295

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.